Ephb4基因多态性与非小细胞肺癌的关系
被引量：1
摘要
目前，人类功能基因组学及疾病基因组学已进入多基因疾病研究领域，而肿瘤被认为是多基因疾病，病因及发病机制尚不完全清楚。单核苷酸多态性（single nucleotide polymorphism，SNP）主要指由基因组核苷酸水平上的变异引起的DNA序列的多样性，是受到高度重视的新一代遗传标志，将构成今后基因组学研究的主要工具。
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
2009年第10期778-779,共2页
Chinese Journal of Oncology
基金
国家自然科学基金（30672400）
参考文献6
-
1Spinola M, Meyer P, KatrLrnerer S, et al. Association of the PDCD5 locus with lung cancer risk and prognosis in smokers, J Clin Oncol, 2006, 24 : 1672-1678.
-
2Mountain CF. Revisions in the international system for staging lung cancer. Chest, 1997, 111 : 1710-1717.
-
3Ihde DC. Chemotherapy of lung cancer. N Eugl J Med, 1992, 327 : 1434-1441.
-
4Hung RJ, Christiani DC, Risch A, el al. International lung cancer consortium : pooled analysis of sequence variants in DNA repair and cell cycle pathways. Cancer Epidemiol Biomarkers Prev, 2008, 17:3081-3089.
-
5McKay JD, Hung RJ, Gaborieau V, et al. Lung cancer susceptibility locus at 5p15.35. Nat Genet, 2008, 40 : 1404-1406.
-
6Loeb LA. A mutator phenotype in cancer Cancer Res, 2001, 61: 3230-3239.
同被引文献15
-
1尹智华,李鸣川,崔泽实,何钦成,周宝森.Relationship between ERCC2 Polymorphism and Risk of Lung Cancer in Chinese Nonsmoker[J].Chinese Journal of Cancer Research,2007,19(3):184-188. 被引量：2
-
2Therasse P,Arbuck SG,Eisenhauer EA. New guidelines to evaluate the response to treatment in solid tumors.European Organization for Research and Treatment of Cancer,National Cancer Institute of the United States,Nationl Cancer Institute of Canada[J].Journal of the National Cancer Institute,2000,(03):205-216.
-
3Giaccone G,Herbst RS,Manegold C. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer:A phase Ⅲ tria-NTACT1[J].Journal of Clinical Oncology,2004,(05):777-784.
-
4Herbst RS,Giaccone G,Schiller JH. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer:A phase Ⅲ tria-NTACT 2[J].Journal of Clinical Oncology,2004,(05):785-794.
-
5Riely GJ,Rizvi NA,Kris MG. Randomized phase Ⅱ study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer[J].Journal of Clinical Oncology,2009,(02):264-270.doi:10.1200/JCO.2008.17.4656.
-
6Shepherd FA,Rodrigues Pereira J,Ciuleanu T. Erlotinib in previously treated non-small-cell lung cancer[J].New England Journal of Medicine,2005,(02):123-132.
-
7Tsao MS,Sakurada A,Cutz JC. Erlotinib in lung cancer molecular and clinical predictors of outcome[J].New England Journal of Medicine,2005,(02):133-144.
-
8ESEL. Gefitinib plus best supportive care in previously treated patient with refractory advanced non-small-cell lung cancer:result from a randomized,placebo controlled,multicentre study (Iressa Survival Evaluation in Lung Cancer)[J].Lancet,2005,(9496):1527-1537.doi:10.1016/S0140-6736(05)67625-8.
-
9Kobayashi S,Boggon TJ,Dayaram T. EGER mutation and resistance of non small lung cancer to gefitinib[J].New England Journal of Medicine,2005,(08):786-792.
-
10Pao W,Miller VA,Politi KA. Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain[J].PLOS MEDICINE,2005,(03):e73.
二级引证文献2
-
1周国仁,冯继锋,陆建伟,吴建中,孙宁,叶劲军.XRCC1、ERCC1单核苷酸多态性与非小细胞肺癌对铂类化疗的敏感性[J].海南医学院学报,2014,20(1):20-24. 被引量：3
-
2李清,张革红.SELDI技术在预测肿瘤化疗药物疗效中的应用[J].中国医学创新,2014,11(15):152-154. 被引量：2
-
1王晓臣,张洪涛,刘泽毅,雷哲,刘仍允,赵军,狄洪震.Ephb4启动子区域甲基化与肺腺癌的关系[J].中国血液流变学杂志,2009,19(1):10-12. 被引量：1
-
2杨亚东,郭海滨,李丽娜,张恩璐.我国汉族人群单核甘酸多态性与前列腺癌风险的相关性研究[J].山东医药,2010,50(46):14-16.
-
3夏红珍,吴强,刘弋,杨枫,杜卫东.VEGF rs3025039和rs3025021多态性与胃癌组织中VEGF、COX-2表达的关系[J].临床与实验病理学杂志,2010,26(2):139-143. 被引量：1
-
4张艳荣,董万利,胡锦,惠国桢,金由辛,史毅.RNA干扰介导EphB4基因表达下调对胶质瘤细胞系U251生长的影响[J].肿瘤,2008,28(12):1042-1046. 被引量：4
-
5余方琳,叶莺,严延生.2型糖尿病易感基因单核甘酸多态性的研究进展[J].中华疾病控制杂志,2016,20(11):1095-1100. 被引量：8
-
6张艳荣,董万利,胡锦,惠国桢.靶向EphB4基因的shRNA真核表达载体的构建与鉴定[J].苏州大学学报（医学版）,2008,28(3):349-352.
-
7黄红艳,朱月永.MicroRNA在肝癌中的研究进展[J].中华全科医学,2010,8(8):1038-1039. 被引量：1
-
8唐英容,郑竹虚,蔡力,姜荣建,周晓芳,陶剑虹,刘明江,陈树,岳林先.AMI患者血浆核苷酸水平与心肌酶的相关性研究[J].医学科技,1994(28):1-4.
-
9文雄.BCR/ABL基因在CML的致病机制及其相关治疗新策略[J].国外医学（内科学分册）,2002,29(7):303-307. 被引量：3
-
10方晓亮,潘骏,顾正勤,康健,齐隽.RNAi抑制人前列腺癌PC3细胞EphB4基因表达的实验研究[J].中国男科学杂志,2009,23(6):6-10. 被引量：1
